Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is risedronate or alendronate more effective at preventing nonvertebral fractures in women with osteoporosis?

A Corrigendum to this article was published on 01 July 2007

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Rossouw JE et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321–333

    Article  CAS  Google Scholar 

  2. McNeil C (2007) Breast cancer decline mirrors fall in hormone use, spurs both debate and research. J Natl Cancer Inst 99: 266–267

    Article  Google Scholar 

  3. Cumming RG et al. (1997) Calcium intake and fracture risk: results from the study of osteoporotic fractures. Am J Epidemiol 145: 926–934

    Article  CAS  Google Scholar 

  4. Cranney A et al. (2002) Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23: 570–578

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rosalind Archer, Editorial Assistant, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dennis M Black.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Black, D., Rosen, C. Is risedronate or alendronate more effective at preventing nonvertebral fractures in women with osteoporosis?. Nat Rev Rheumatol 3, 378–379 (2007). https://doi.org/10.1038/ncprheum0530

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0530

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing